Litigation Details for ALLERGAN SALES, LLC v. SANDOZ, INC. (D.N.J. 2017)

ALLERGAN SALES, LLC v. SANDOZ, INC. (D.N.J. 2017)

Docket		Date Filed	2017-10-30
Court	District Court, D. New Jersey	Date Terminated	2022-01-28
Cause	35:271 Patent Infringement	Assigned To	Claire Claudia Cecchi
Jury Demand	Both	Referred To	Edward S. Kiel
Parties	HON. DENNIS M. CAVANAUGH
Patents	7,030,149; 7,320,976; 7,323,463; 7,642,258; 8,133,890; 8,354,409; 8,748,425; 9,474,751; 9,770,453; 9,907,801; 9,907,802
Attorneys	HECTOR DANIEL RUIZ
Firms	Eric I. Abraham
Link to Docket	External link to docket

Details for ALLERGAN SALES, LLC v. SANDOZ, INC. (D.N.J. 2017)

Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2017-10-30	1		formulation of Combigan®. The listed patents are U.S. Patent Nos. 7,030,149, 7,320,976, 7,642,258, 8,133,890…infringed U.S. Patent Nos. 7,030,149, 7,320,976, 7,323,463, and 7,642,258, and that those patents were not …latest of the expiration dates of U.S. Patent Nos. 7,030,149, 7,320,976, 7,323,463, and 7,642,258. …that the claims of the ’149 patent, ’258 patent, ’976 patent, and ’425 patent are invalid and/or will not… infringement of United States Patent No. 9,770,453 (the “’453 patent”) under 35 U.S.C. § 271(e)(2) and	External link to document
2018-05-22	112		the first patent from which issued in 2006, U.S. Patent No. 7,030,149 (the “’149 patent”). (Id. ¶¶…the “’801 patent”), and 9,907,802 (the “’802 patent). These patents all stem from a patent application… ’149 patent, the ’425 patent, and a third patent from the first litigation, the ’976 patent. 6 (Id…other patents, U.S. Patent Nos. 8,133,890 (the “’890 patent”) and 8,354,409 (the “’409 patent”) that…Allergan Patent Family beginning with the first patent of this family, the ’149 patent. The inequitable	External link to document